MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease

The administration of hepatitis C virus (HCV) NS3/4A protease inhibitors to patients with chronic HCV infections has demonstrated that they have dramatic antiviral effects and that compounds acting via this mechanism are likely to form a key component of future anti-HCV therapy. We report here on th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liverton, Nigel J., Carroll, Steven S., DiMuzio, Jillian, Fandozzi, Christine, Graham, Donald J., Hazuda, Daria, Holloway, M. Katherine, Ludmerer, Steven W., McCauley, John A., McIntyre, Charles J., Olsen, David B., Rudd, Michael T., Stahlhut, Mark, Vacca, Joseph P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2010
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2798506/
https://ncbi.nlm.nih.gov/pubmed/19841155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00677-09
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados